PREMARKET NEWS REPORT Dec 9, 2025

1. MAJOR NEWS

• US — Equity futures edge higher with the S&P 500 hovering just below record territory as investors brace for this week’s Fed meeting, where markets are pricing in another 25 bps cut but remain split on the 2026 path for rates (WSJ, MarketWatch, CNBC).
• US — Treasury yields are mixed ahead of the decision, while the CNN Fear & Greed gauge sits in “fear” at 31, underscoring cautious positioning despite resilient risk assets (Benzinga, CNN, Stocknear sentiment data).
• Global — Major world indices are positive year-to-date with Hong Kong’s Hang Seng up about 31.3%, and precious metals enter a “pivotal week” as traders weigh the Fed’s final 2025 move and a looming US $15T 2026–2028 “debt wall” that could pressure liquidity (Reuters, MarketWatch, Investing.com).
• China/US Tech — President Trump has approved exports of NVDA H200 AI chips to “approved” Chinese customers in exchange for a US revenue cut of up to 25%, easing some national-security curbs while reinforcing US take on AI hardware profits (Reuters, WSJ, NYT).
• EU/Australia — Brussels opened an antitrust probe into Alphabet’s AI use of publisher content, while Australia’s under‑16 social‑media ban takes effect this week, forcing Meta, TikTok and YouTube to block or log out more than 1 million+ teen accounts and signalling a tougher global stance on platform liability (Reuters, FT, Axios).

2. SPECULATIVE POSITIONING

Index options traders remain aggressively call‑biased with an S&P 500 put/call volume near 0.20, even as overall sentiment sits in ‘fear’ and total index call volume runs at roughly 5x puts – Stocknear options & sentiment data.

3. MAG7 COVERAGE

• NVDA — Trades near $185.57 (about +1.7%) as the Trump approval of H200 exports to China unlocks a potentially multi‑billion‑dollar revenue stream; Street remains bullish with a median target around $250 and deep 2026–2027 protective puts at the $150 strike highlight long‑dated hedging alongside upside call blocks into the 25/02 earnings (WSJ, Reuters, Stocknear options).
• AAPL — Around $277.89 (roughly -0.3%) amid continued executive turnover and AI re‑org headlines, but analysts are leaning into 2026 with fresh Buys and price targets up to $350, while chunky 2026 $285–$320 call blocks and institutional blocks over $1.4B suggest funds are buying any weakness into the 29/01 print (Evercore, Wedbush, Stocknear dark pool & options).
• MSFT — Trades near $491.02 (about +1.6%) after shaking off last week’s AI‑demand scare; more than $5B in recent blocks and 2025–2026 put structures in the $535–$550 zone point to heavy institutional hedging rather than derisking ahead of 28/01 earnings, with a Street median target near $640 (DA Davidson, JPM, options tape).
• AMZN — Around $227.00 (about -1.1%) as investors digest AWS re:Invent: Trainium2 is already at a multi‑billion run‑rate and Trainium3 plus “AI Factories” should support capex above $125B by 2026; options skew shows heavy 2026–2027 downside puts at $170–$210 paired with upside calls around $300, consistent with a bullish but risk‑managed AI thesis into 05/02 earnings (BofA, Reuters, Stocknear options).
• GOOGL — Trades near $313.72 (about -2.4%) as an EU antitrust probe into AI content use hits the stock after a stellar run; DA Davidson now values Alphabet’s home‑grown TPU business at up to $900B, with massive 2027 deep‑in‑the‑money call structures and multi‑hundred‑million dollar single‑stock blocks reinforcing long‑duration AI‑chip exposure ahead of 03/02 earnings (DA Davidson, Reuters, Stocknear block data).
• META — Around $667.07 (roughly -0.9%) after reports it may cut metaverse spend by up to 30% while redirecting capital to AI and wearables; flows show large 2027 $700–$800 upside calls paired with protective downside puts, and Reality Labs belt‑tightening is being read as margin‑accretive into 28/01 earnings (Bloomberg, UBS, Stocknear options).
• TSLA — Trades near $439.58 (about -3.4%) as Morgan Stanley downgrades the stock to Hold with a $425 PT on valuation concerns, even as China November volumes stay strong; options remain dominated by 2026–2028 downside puts in the $320–$460 band and a recent 846k‑share block around $413 underscores both institutional scale and skepticism about sustaining the current ~231x P/E into 28/01 earnings (Morgan Stanley, CPCA, dark‑pool tape).

4. OTHER COMPANIES / SECTOR THEMES

• Biotech / SMID — INCY Upgrades by Salim Syed (Baird) to Outperform with $121 PT (25.1% upside), arguing that the pipeline and royalty streams are underappreciated relative to current valuations (Baird).

• Software / Data Streaming — CFLT Downgrades by Ryan Macwilliams (Barclays) to Equal‑Weight with $31 PT (about 3.8% upside) as he cites rich post‑rally multiples and mounting competitive intensity in streaming platforms (Barclays).

• Regional Banks — CUBI Initiates Coverage by Brian Wilczynski (Wolfe) to Equal‑Weight with $90 PT (~26.9% upside), highlighting balance‑sheet repair and solid NIM but limited re‑rating until macro visibility improves (Wolfe).

• Industrial / Capital Goods — ITT Maintains by Matt Summerville (D.A. Davidson) to Buy with $215 PT (~27.0% upside), seeing structurally higher margins and infrastructure exposure offsetting cyclical softness (DA Davidson).

• Semis / AI Infrastructure — TEVA Maintains by Matt Dellatorre (Cowen) to Strong Buy with $31 PT (~9.4% upside), pointing to deleveraging and a more durable branded/complex‑generic mix supporting multiple expansion (Cowen).

• Healthcare / Diagnostics — BMI Maintains by Michael Fairbanks (JPM) to Overweight with $235 PT (~32.4% upside), as he sees pricing power and secular water‑infrastructure demand outweighing near‑term macro headwinds (JPM).

• Media / Exhibitors — IMAX Maintains by Steve Frankel (Roth) to Strong Buy with $47 PT (~22.1% upside), citing a robust blockbuster slate and premium‑screen economics that should drive EBITDA leverage (Roth).

• Digital Infrastructure / REITs — DBRG Maintains by Jonathan Atkin (RBC) to Outperform with $23 PT (~53.0% upside) as he highlights accelerating AI‑driven data‑center demand versus still‑depressed valuations (RBC).

• Online Real Estate / SaaS — CSGP Reiterates by Mayank Tandon (Needham) to Buy with $105 PT (~58.3% upside), expecting data‑network effects and AI‑enhanced search to sustain premium growth multiples (Needham).

• Specialty Pharma — MNOV Maintains by Jason Kolbert (Maxim) to Buy with $9 PT (about 496% upside), framed as a high‑risk, high‑reward play on underpriced CNS assets (Maxim).

• Consumer / Entertainment — CAN Initiates Coverage by Gregory Lewis (BTIG) to Buy with $3 PT (~219% upside), emphasizing leverage to crypto‑mining cycles and upside torque if Bitcoin strength persists (BTIG).